NCT00110942View on ClinicalTrials.gov

Treatment for Patients With Osteoarthritis (OA)

PHASE2CompletedINTERVENTIONAL

Enrollment

160

Participants

Timeline

Start Date

February 28, 2005

Primary Completion Date

June 30, 2005

Study Completion Date

November 30, 2005

Conditions

Osteoarthritis

Interventions

DRUG

Systemic AMG 108

300 mg SC AMG 108 Q4W for 3 doses

OTHER

Placebo

SC placebo injection Q4W for 3 doses

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Amgen

INDUSTRY